

Sequential
Advancing health through microbiome science
Clinical microbiome analysis for personal care and pharma with a 20,000+ sample database, in vivo certification, and full clinical study support.
- • NGS & molecular diagnostics
- • End-to-end clinical platform
- • Scientifically validated products
Interesting facts
Origin of the Startup Idea
As scientists, we often celebrate breakthroughs within our own world -but too often, their impact reaches only a few. Our vision was born from a simple belief: science should be accessible to everyone. We see our skin every day, and we share an intimate relationship with it. That’s why we bring our knowledge of biology to life through the skin microbiome -turning science into solutions people can truly use.
Hidden Talent Most People Wouldn’t Expect
A knack for drawing. In particularly realism. It’s a quiet creative outlet that balances the intensity of building a business.
If Not an Entrepreneur, I’d Be…
Professional football player.
Childhood Inspiration or Origin Story
No particular childhood inspiration, bud a deep admiration for innovators who bridged the gap between science and everyday life.
Advice to Someone Just Starting
Spend time finding the right co-founder and building a successful team. Success doesn’t come from an idea alone but from the people who bring it to life together.
Quote Snippet / Pull Quote
“Science should not stay in the lab — it should be in people’s hands”
“The right co-founder is worth more than the right idea”
Founder Biography & Company Overview
Sequential was founded in 2021 by Dr. Oliver Worsley and Dr. Albert Dashi, two award-winning scientists with a shared vision of advancing human health through microbiome science. Dr. Worsley, CEO, holds a PhD in molecular genetics from the Genome Institute of Singapore and has received multiple international innovation awards. Dr. Dashi, CSO, earned his PhD in molecular genetics, epigenetics, and stem cell research from the National University of Singapore, and is recognized for his contributions to scientific research and entrepreneurship. Together, they lead a multidisciplinary team of experts in genetics, microbiology, clinical research, and skincare innovation.
Sequential is a pioneering medtech company specializing in clinical microbiome analysis for the personal care and pharmaceutical industries. Our mission is to decode the complex interactions between the human host and microbiome to drive innovation and improve health outcomes. With one of the industry’s most advanced human microbiome databases housing over 20,000 samples, we deliver a robust end-to-end platform that includes in vivo microbiome certification, biophysical assessments, and full clinical study support. Our cutting-edge platform uses next-generation sequencing (NGS) and molecular diagnostics to generate actionable, real-world data that help partners develop scientifically validated, differentiated products. By combining deep scientific expertise with clinical rigor, Sequential is setting new industry standards in microbiome testing and shaping a future where healthier microbiomes lead to better, more effective products and care.